Bank of New York Mellon’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.09M | Buy |
612,470
+15,951
| +3% | +$80.4K | ﹤0.01% | 2523 |
|
2025
Q1 | $3.87M | Sell |
596,519
-7,548
| -1% | -$48.9K | ﹤0.01% | 2350 |
|
2024
Q4 | $4.43M | Sell |
604,067
-38,216
| -6% | -$281K | ﹤0.01% | 2347 |
|
2024
Q3 | $4.81M | Sell |
642,283
-171,005
| -21% | -$1.28M | ﹤0.01% | 2305 |
|
2024
Q2 | $7.24M | Buy |
813,288
+6,359
| +0.8% | +$56.6K | ﹤0.01% | 2135 |
|
2024
Q1 | $8.17M | Buy |
806,929
+86,031
| +12% | +$871K | ﹤0.01% | 2061 |
|
2023
Q4 | $7.25M | Sell |
720,898
-140,586
| -16% | -$1.41M | ﹤0.01% | 2175 |
|
2023
Q3 | $8.07M | Buy |
861,484
+24,492
| +3% | +$229K | ﹤0.01% | 2060 |
|
2023
Q2 | $20.5M | Buy |
836,992
+13,824
| +2% | +$339K | ﹤0.01% | 1542 |
|
2023
Q1 | $19.2M | Sell |
823,168
-13,232
| -2% | -$308K | ﹤0.01% | 1567 |
|
2022
Q4 | $21.2M | Buy |
836,400
+106,313
| +15% | +$2.69M | ﹤0.01% | 1508 |
|
2022
Q3 | $14.1M | Buy |
730,087
+28,094
| +4% | +$542K | ﹤0.01% | 1693 |
|
2022
Q2 | $17.9M | Buy |
701,993
+427,490
| +156% | +$10.9M | ﹤0.01% | 1596 |
|
2022
Q1 | $7.06M | Sell |
274,503
-4,381
| -2% | -$113K | ﹤0.01% | 2257 |
|
2021
Q4 | $11.7M | Buy |
278,884
+17,132
| +7% | +$717K | ﹤0.01% | 2022 |
|
2021
Q3 | $11.4M | Buy |
261,752
+21,861
| +9% | +$951K | ﹤0.01% | 2046 |
|
2021
Q2 | $11.3M | Buy |
239,891
+68,585
| +40% | +$3.24M | ﹤0.01% | 2061 |
|
2021
Q1 | $8.78M | Sell |
171,306
-9,919
| -5% | -$508K | ﹤0.01% | 2160 |
|
2020
Q4 | $4.85M | Buy |
181,225
+16,219
| +10% | +$434K | ﹤0.01% | 2368 |
|
2020
Q3 | $5.66M | Buy |
165,006
+41,176
| +33% | +$1.41M | ﹤0.01% | 2151 |
|
2020
Q2 | $5.07M | Buy |
123,830
+104,213
| +531% | +$4.27M | ﹤0.01% | 2200 |
|
2020
Q1 | $672K | Buy |
19,617
+6,674
| +52% | +$229K | ﹤0.01% | 3223 |
|
2019
Q4 | $163K | Buy |
+12,943
| New | +$163K | ﹤0.01% | 3953 |
|